The Neuropsychiatric and Neuropsychological Features of Chronic Fatigue Syndrome: Revisiting the Enigma
- 729 Downloads
The aim of this article is to provide a comprehensive and updated review of the key neuropsychiatric and neuropsychological complaints associated with chronic fatigue syndrome (CFS). Neuropsychiatric and neuropsychological difficulties are common in CFS and are linked primarily to disorders of mood, affect and behaviour. The neuropsychiatric complaint most frequently encountered amongst CFS patients is depression and in particular major depressive disorder (MDD). Despite decades of research, the precise aetiological relationship between CFS and MDD remains poorly understood. This has resulted in the development of a number of interesting and polarised hypotheses regarding the aetiological nature of CFS. Recent scientific advances have however begun to unravel a number of interesting inflammatory and immunological explanations that suggest CFS and MDD are distinct yet interrelated conditions. The possibility that the overlap between CFS and MDD might be explained in terms of shared oxidative and nitrosative (IO&NS) pathways is an area of intense research interest and is reviewed in detail in this article. The overlap between CFS and MDD is further differentiated by variations in HPA axis activity between the two disorders. Important immunological differences between MDD and CFS are also reviewed with particular emphasis on antiviral RNase L pathways in CFS. In addition to the presence of neuropsychiatric complaints, CFS is also associated with neuropsychological symptoms such as impaired attention, memory and reaction time. The key neuropsychological problems reported by CFS patients are also included in the review in an effort to understand the significance of cognitive impairment in CFS.
KeywordsChronic fatigue syndrome CFS Depression Generalised anxiety disorder Neuropsychiatric Neuropsychological Major depressive disorder MDD Somatoform disorder Personality disorder Attention Memory Reaction time
Y. Christley declares that she has no conflict of interest.
T. Duffy declares that he has no conflict of interest.
I. P. Everall has received compensation for lectures including service on speakers’ bureaus from Abbot and AstraZeneca.
C. R. Martin declares that he has no conflict of interest.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 1.•• Christley Y, Duffy T, Martin CR. A review of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract. 2012;18:25–31. This important paper highlights longstanding inconsistencies and irregularities in definitional criteria regarding CFS and the implications that these enduring inconsistencies may have on developing convincing aetiological accounts. PubMedCrossRefGoogle Scholar
- 10.Iwase M, Okajima R, Takahashi T, Mogami N, Kusaka H, Takeda M, et al. Psychiatric treatment and assessment of chronic fatigue syndrome in Japan. In: Watanabe Y, Evengård B, Natelson BH, Jason LA, Kuratsune H, editors. Fatigue science for human health. Springer: London; 2008. p. 103–19.Google Scholar
- 16.Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012;36:764–85.PubMedCrossRefGoogle Scholar
- 24.Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients-A case control study. Bmc Neurol. 2011; 11.Google Scholar
- 30.Maes M, Twisk FNM. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a multisystem disease, should target the pathophysiological aberrations (inflammatory and oxidative and nitrosative stress pathways), not the psychosocial “barriers” for a new equilibrium. Patient Educ Couns. 2010;80:148–9.PubMedCrossRefGoogle Scholar
- 31.Maes M, Mihaylova I, Leunis JC. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 2007;28:861–7.PubMedGoogle Scholar
- 34.Maes M, Twisk FNM. Chronic fatigue syndrome: Harvey and Wessely’s (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. Bmc Medicine, 2010; 8.Google Scholar
- 35.Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, Otte C. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: A longitudinal study. Psychoneuroendocrinology, 2011.Google Scholar
- 47.Suhadolnik RJ, Peterson DL, Reichenbach NL, Roen G, Metzger M, McCahan J, et al. Clinical and biochemical characteristics differentiating chronic fatigue syndrome from major depression and healthy control populations: relation to dysfunction in the RNase L pathway. J Chron Fatigue Syndr. 2004;12:5–35.CrossRefGoogle Scholar
- 50.Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatr Clin Neurosci. 1993;5:200–5.Google Scholar
- 52.Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatr Rev Can Psychiatr. 2006;51:100–13.Google Scholar
- 56.Nutt DJ. Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatr. 2001;62 Suppl 11:22–7. discussion 28.Google Scholar
- 62.Demitrack MA. Neuroendocrine research strategies in chronic fatigue syndrome. In: Goodnick PJ, Klimas NG, editors. Chronic fatigue and related immune deficiency syndromes. Washington: American Psychiatric Press; 1993. p. 45–66.Google Scholar
- 81.•• Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients—a case control study. BMC Neurol. 2011;11:82. This excellent paper highlights evidence of important and distinguising features of abnormal brain physiology suggesting temporal lobe involvement in CFS. PubMedCrossRefGoogle Scholar